Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Developing a Prognostic Score for Patients with Acute Intracerebral Hemorrhage
EF 2011-12
Résumé
Intracerebral hemorrhage (ICH), also known as hemorrhagic stroke, is characterized by spontaneous bleeding within the brain and affects over 5000 Canadians and 67,000 Americans annually. Patients with ICH have worse outcomes than other stroke types with 50-60% of patients experiencing death or severe disability. Increase in hemorrhage size within the first 24 hours, also known as hemorrhage expansion (HE), occurs in one-third of patients and suggests on-going bleeding. HE is strongly associated with death and disability. Multiple therapies to limit HE, including treatment with rapid clotting agent or blood pressure lowering, have been able to reduce HE however have not been able to show improved clinical outcomes. One attributed reason for this has been the fact that all ICH patients received treatment in these trials. Treating all patients results in exposing two-thirds of patients who will not experience HE to treatment side effects without benefit. It also dilutes the overall observed clinical effects potentially seen in those with HE. Accurately predicting and treating only those patients most likely to have HE is thus critical. The best marker for predicting HE thus far has been detection of active bleeding on head CAT scans as demonstrated by dye leakage into the hemorrhage. Our research group has confirmed the reliable nature of this marker and have accumulated one of the largest international high-quality patient databases characterizing this finding along with other important clinical and laboratory patient characteristics for predicting HE and poor outcome. Using our data, we aim to create a quick, accurate, and reliable clinical scoring system that will allow physicians to predict hematoma expansion and poor outcome and to select treatments for ICH patients accordingly. This score will help ensure those patients likely to receive benefit from treatments will receive it and those unlikely to benefit will be spared from the treatment side effects.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
255392
Name
Huynh Thien J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Developing a Prognostic Score for Patients with Acute Intracerebral Hemorrhage
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cerebral Hemorrhage; Clinical Prediction Rule; Contrast Extravasation; Hematoma Expansion; Multivariable Logistic Regression; Spot Sign; Stroke
Abstract
Intracerebral hemorrhage (ICH), also known as hemorrhagic stroke, is characterized by spontaneous bleeding within the brain and affects over 5000 Canadians and 67,000 Americans annually. Patients with ICH have worse outcomes than other stroke types with 50-60% of patients experiencing death or severe disability. Increase in hemorrhage size within the first 24 hours, also known as hemorrhage expansion (HE), occurs in one-third of patients and suggests on-going bleeding. HE is strongly associated with death and disability. Multiple therapies to limit HE, including treatment with rapid clotting agent or blood pressure lowering, have been able to reduce HE however have not been able to show improved clinical outcomes. One attributed reason for this has been the fact that all ICH patients received treatment in these trials. Treating all patients results in exposing two-thirds of patients who will not experience HE to treatment side effects without benefit. It also dilutes the overall observed clinical effects potentially seen in those with HE. Accurately predicting and treating only those patients most likely to have HE is thus critical. The best marker for predicting HE thus far has been detection of active bleeding on head CAT scans as demonstrated by dye leakage into the hemorrhage. Our research group has confirmed the reliable nature of this marker and have accumulated one of the largest international high-quality patient databases characterizing this finding along with other important clinical and laboratory patient characteristics for predicting HE and poor outcome. Using our data, we aim to create a quick, accurate, and reliable clinical scoring system that will allow physicians to predict hematoma expansion and poor outcome and to select treatments for ICH patients accordingly. This score will help ensure those patients likely to receive benefit from treatments will receive it and those unlikely to benefit will be spared from the treatment side effects.
Competitiondate
201202
Approvedterm2
1 yr 0 mth
Pinamesdelim
Huynh, Thien J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~